Evogene Earnings Fall Short at $0.30, Profit Below Expectations

According to Evogene's (NASDAQ: EVGN) report, the earnings per share for the third quarter were -$1.310, which is $0.30 worse than the analysts' expectations of -$1.010. The revenue for this quarter was determined to be $1.8M, while analyst expectations were at $2.85M.

Evogene's stock closed the day at $1.65. This level indicates that the company has lost -57.470% of its value over the last three months. Over the past 12 months, the stock has shown a decrease of -72.650%. In the last 90 days, Evogene has seen 0 positive earnings per share while recording 1 negative earnings per share. You can review how Evogene's stock price reacted to past earnings reports here. According to InvestingPro, Evogene's financial health score is "Very Good Performance." You can explore the latest earnings reports and all financial information related to Evogene here. Stay informed about all developments regarding financial statements by visiting the Investing.com Earnings Calendar.